Double-stranded RNA correction of abnormalities in circulating i

Details Double-stranded RNA correction of abnormalities in circulating i Double-stranded RNA correction of abnormalities in circulating i

1991-05-06

1992-02-25

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514885, 536 27, 536 28, 536 29, A61K 3170

Patent

active

050913743

ABSTRACT:
Abnormalities in the circulating immune complexes in a patient's blood, such as observed in patients having inflammatory disorders, viral infections, or simply deranged immune function, are restored to normal or viral immunity conferred by the administration of a matched or mismatched dsRNA.

REFERENCES:
patent: 3796631 (1974-03-01), Choay et al.
patent: 4020696 (1989-04-01), Carter
patent: 4024241 (1977-05-01), Levy
patent: 4130641 (1978-12-01), Ts'o et al.
patent: 4313938 (1982-02-01), Arimura et al.
patent: 4400375 (1983-08-01), Douthart et al.
patent: 4795744 (1989-01-01), Carter
patent: 4950652 (1990-08-01), Carter
Levy et al., Proceeding of National Academy of Science 62, No. 2 pp. 357-361 (1969).
Krown et al., The Chemical Abstracts 106: 154300s (1987).
Kleinerman et al., The Chemical Abstracts 105: 189137a (1986).
Zueva et al., The Chemical Abstracts 104: 18454b (1986).
Pahwa et al., The Chemical Abstracts 99: 36952v (1983).

Affiliated with

Also associated with

Rating

Double-stranded RNA correction of abnormalities in circulating i does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Double-stranded RNA correction of abnormalities in circulating i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Double-stranded RNA correction of abnormalities in circulating i will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1893030